OLMA ▲ +2.3% - Olema Pharmaceuticals, Inc. $OLMA - Olema Oncology to Present Combination Data from the Palazestrant and OP-3136 Programs at the 2026 San Antonio Breast Cancer Symposium 04-NOV-2026 04:01 PM ET